Genetron Holdings Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Genetron Holdings.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Biotechs earnings growth | 24.5% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
Recent updates
Genetron Holdings GAAP EPS of -$0.08, revenue of $20.56M
Oct 12China's Genetron gets acquisition offer from co-founder/CEO
Aug 22Are Investors Undervaluing Genetron Holdings Limited (NASDAQ:GTH) By 27%?
Dec 07Genetron Holdings Limited's (NASDAQ:GTH) Intrinsic Value Is Potentially 24% Below Its Share Price
Aug 17Genetron Holdings Limited (NASDAQ:GTH) Released Earnings Last Week And Analysts Lifted Their Price Target To US$26.22
Mar 27Is Genetron Holdings Limited (NASDAQ:GTH) Popular Amongst Insiders?
Feb 25Genetron Health, Sino Biopharm's subsidiary inks strategic partnership for HCCscreen in China
Jan 06Genetron up 2% after HCCscreen selected by NCC, Wuxi for public health initiative in China
Nov 27Genetron (GTH) Investor Presentation - Slideshow
Nov 18Genetron Holdings reports Q3 results
Nov 09In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Genetron Holdings has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2022 | 651 | -808 | -542 | -460 | N/A |
9/30/2022 | 596 | -772 | N/A | N/A | N/A |
6/30/2022 | 547 | -701 | N/A | N/A | N/A |
3/31/2022 | 550 | -558 | N/A | N/A | N/A |
12/31/2021 | 532 | -496 | -610 | -524 | N/A |
9/30/2021 | 519 | -407 | N/A | N/A | N/A |
6/30/2021 | 478 | -326 | N/A | N/A | N/A |
3/31/2021 | 440 | -3,066 | N/A | N/A | N/A |
12/31/2020 | 424 | -3,069 | -351 | -301 | N/A |
9/30/2020 | 393 | -3,131 | N/A | N/A | N/A |
6/30/2020 | 363 | -3,357 | N/A | N/A | N/A |
3/31/2020 | 334 | -660 | -237 | -209 | N/A |
12/31/2019 | 323 | -676 | -223 | -197 | N/A |
9/30/2019 | 294 | -666 | -193 | -165 | N/A |
12/31/2018 | 225 | -465 | -248 | -201 | N/A |
12/31/2017 | 101 | -421 | -151 | -130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if GTH's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if GTH's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if GTH's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if GTH's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if GTH's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if GTH's Return on Equity is forecast to be high in 3 years time